HALO

Halozyme Therapeutics, Inc. News Headlines

$12.38
*  
0.11
0.9%
Get HALO Alerts
*Delayed - data as of Feb. 27, 2017 10:34 ET  -  Find a broker to begin trading HALO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    HALO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Latest News






















News From Around The Web

Pancreatic Cancer Field Awaits Sparse Data
1/24/2017 1:27:00 PM - Seeking Alpha




Halozyme Estimates 2017 Revenue of $115M to $130M
1/11/2017 10:03:00 AM - Investopedia


Halozyme Pancreatic Cancer Drug Succeeds in Trial
1/6/2017 9:34:00 AM - Investopedia


Trump Rally Took A Break - Cramer's Mad Money (1/5/17)
1/6/2017 7:39:00 AM - Seeking Alpha